Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 31.75
+0.45 (1.44%)
Aug 26, 2026, 11:52 AM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 1.02 billion as of August 25, 2026. Its market cap has decreased by -3.69% in one year.
Market Cap
1.02B
Enterprise Value
827.78M
Revenue
709.37M
Ranking
n/a
PE Ratio
13.43
Stock Price
31.75
ChartMarket Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 1.02B, an increase of 306.83%. That is a compound annual growth rate of 6.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 1.02B | -5.15% |
| Dec 31, 2025 | 1.07B | 3.13% |
| Dec 31, 2024 | 1.04B | 5.09% |
| Dec 29, 2023 | 988.19M | 10.13% |
| Dec 30, 2022 | 897.32M | -7.68% |
| Dec 30, 2021 | 971.96M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.26B |
| Enimmune | 1.19B |
| U-Neuron Biomedical | 1.15B |
| LabTurbo Biotech | 1.12B |
| BiOptic | 1.12B |
| Bio Preventive Medicine | 1.09B |
| Lukas Biomedical | 1.03B |
| GeneReach Biotechnology | 979.88M |